MacroGenics (MGNX) PT Raised to $37 at Wedbush on MARGENZA Approval

December 17, 2020 12:40 PM EST
Get Alerts MGNX Hot Sheet
Price: $25.43 -1.36%

Rating Summary:
    17 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 25 | Down: 37 | New: 115
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten raised the price target on MacroGenics (NASDAQ: MGNX) to $37.00 (from $32.00) while maintaining an Outperform rating after MARGENZA was approved in HER2+ mBC.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change